Lauren May

Professional Summary for Professor Lauren May

Professor Lauren May is a distinguished academic and researcher at Monash University, Australia, with a focus on pharmacology and drug discovery. Her work has significantly contributed to the understanding of G protein-coupled receptor (GPCR) signaling, a critical area in therapeutic development. Based at the Monash Institute of Pharmaceutical Sciences, she is recognized for her innovative approaches to studying receptor pharmacology and her collaborative efforts in advancing medical research.

Academic Background and Degrees

Professor May holds advanced degrees in pharmacology, reflecting her deep expertise in the field. While specific details of her educational institutions and graduation years are not fully disclosed in public records, her academic credentials are evidenced by her senior roles and contributions at Monash University.

Research Specializations and Academic Interests

Professor May specializes in the pharmacology of G protein-coupled receptors (GPCRs), with a particular interest in:

• Receptor signaling mechanisms and biased agonism
• Drug discovery and development targeting GPCRs
• Therapeutic applications for cardiovascular and metabolic diseases

Her research integrates cutting-edge techniques in molecular pharmacology to uncover novel therapeutic targets, contributing to advancements in precision medicine.

Career History and Appointments

Professor May has built a notable career at Monash University, where she holds a senior academic position within the Monash Institute of Pharmaceutical Sciences. Key milestones in her career include:

• Associate Professor and later Professor at Monash University
• Head of the Drug Discovery Biology theme at Monash Institute of Pharmaceutical Sciences
• Active collaborator in interdisciplinary research teams focusing on pharmacology and drug development

Major Awards, Fellowships, and Honors

Professor May has received recognition for her contributions to pharmacology and drug discovery. While specific awards are not exhaustively detailed in public sources, her leadership roles and high-impact research indicate a strong reputation within the academic community. Notable honors include:

• Invitations to speak at international conferences on GPCR pharmacology
• Recognition through competitive research funding and grants from Australian research bodies

Key Publications

Professor May has authored numerous high-impact publications in the field of pharmacology. A selection of her notable works includes:

• 'Biased agonism at G protein-coupled receptors: the promise and the challenges—a medicinal chemistry perspective' (2014) - Published in Medicinal Research Reviews
• 'Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors' (2007) - Published in Molecular Pharmacology
• 'Allosteric modulation of G protein-coupled receptors: A pharmacological perspective' (2011) - Published in Neuropharmacology

Her publications are widely cited, reflecting her influence in advancing the understanding of receptor signaling and drug targeting.

Influence and Impact on Academic Field

Professor May’s research on GPCR signaling has had a profound impact on the field of pharmacology, particularly in the development of novel therapeutic strategies. Her work on biased agonism and allosteric modulation has provided critical insights into designing drugs with greater specificity and fewer side effects. She is regarded as a leader in her field, evidenced by her mentorship of early-career researchers and her contributions to collaborative research initiatives at Monash University.

Public Lectures, Committee Roles, and Editorial Contributions

Professor May is actively involved in the broader academic community through various roles, including:

• Delivering invited lectures and presentations at international pharmacology conferences
• Serving on editorial boards and as a peer reviewer for leading journals in pharmacology (specific journals not publicly listed)
• Participation in scientific committees and advisory panels focused on drug discovery and receptor biology

Her engagement in these activities underscores her commitment to advancing scientific knowledge and fostering collaboration in her field.